ALLO
Allogene Therapeutics Inc
NASDAQ: ALLO · HEALTHCARE · BIOTECHNOLOGY
$2.13
+0.95% today
Updated 2026-04-30
Market cap
$794.59M
P/E ratio
—
P/S ratio
7,784.36x
EPS (TTM)
$-0.87
Dividend yield
—
52W range
$1 – $4
Volume
10.3M
Allogene Therapeutics Inc (ALLO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $38.34M | $38.49M | $243000.00 | $95000.00 | $22000.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | +0.4% | -99.4% | -60.9% | -76.8% | -100.0% |
| Cost of revenue | $0.00 | $1.50M | $5.03M | $11.54M | $13.06M | $16.73M | $14.20M | $13.64M | $12.36M |
| Gross profit | $0.00 | $-1.50M | $-5.03M | $-11.54M | $38.49M | $243000.00 | $95000.00 | $22000.00 | $-12.36M |
| Gross margin | — | — | — | -30.1% | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D | $151.86M | $151.86M | $144.53M | $192.99M | $220.18M | $256.39M | $242.91M | $192.30M | $150.15M |
| SG&A | $24000.00 | $40.98M | $57.47M | $65.26M | $74.11M | $79.31M | $71.67M | $65.20M | $56.78M |
| Operating income | $-2000.00 | $-192.84M | $-202.01M | $-258.24M | $-255.79M | $-335.45M | $-327.74M | $-273.20M | $-206.93M |
| Operating margin | — | — | — | -673.5% | -664.6% | -138044.9% | -344986.3% | -1241813.6% | — |
| EBITDA | $22000.00 | $-206.76M | $-179.90M | $-250.66M | $-245.34M | $-321.15M | $-313.07M | $-243.33M | $-194.57M |
| EBITDA margin | — | — | — | -653.7% | -637.4% | -132162.1% | -329543.2% | -1106031.8% | — |
| EBIT | $-2000.00 | $-208.26M | $-184.93M | $-258.24M | $-255.79M | $-335.45M | $-327.26M | $-256.97M | $-206.93M |
| Interest expense | $0.00 | $3.36M | $5.03M | $9.16M | $10.45M | $17.11M | $17.11M | $181000.00 | $1.07M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2000.00 | $-211.50M | $-184.59M | $-233.47M | $-244.84M | $-329.81M | $-327.26M | $-257.59M | $-190.89M |
| Net income growth (YoY) | — | -10575150.0% | +12.7% | -26.5% | -4.9% | -34.7% | +0.8% | +21.3% | +25.9% |
| Profit margin | — | — | — | -608.9% | -636.1% | -135726.3% | -344489.5% | -1170863.6% | — |